Vision Research Report, Recently Announced New Report on “patient engagement solutions market – Global Industry Analysis, Market Size, Share, Growth, Trends, Region Outlook, And Segment Forecasts, 2021 – 2030″.
Global “Patient engagement solutions market” Report 2021 covering manufacturers, regions, segments, forecast to 2030 is that the recent research report with correct information and extremely authentic info. The report provides insights on market share, market size, rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, and distributors. The Patient engagement solutions research report focuses on the competitive surroundings that has section on company profile covering product specifications, geographical coverage, recent developments, revenue analysis, and market shares. what is more, the report offers strategic recommendations so as to help the consumers to align business goals.
The Patient engagement solutions market revenue share is set to grow at a yearly rate of 17.3% during 2021-2030, while its valuation is Projected to jump from $ 15.6 Bn in 2020 to $70.2 Bn in 2030.
Get Sample Copy of This Report@ https://www.visionresearchreports.com/report/sample/39139
By Delivery Type Analysis
The web and cloud-based segment dominated the market in 2021 with a revenue share of over 75.0%. The segment is also anticipated to expand at the fastest rate over the forecast period.
The platform is intended to aid providers to advance patient engagement and association among health teams with features such as telehealth and data analytics. On-premise services provide patient data security, easy retrieval, and ease of access.
By Component Analysis
The software and hardware segment accounted for the largest share of over 60.0% in 2021 and is expected to expand at the fastest CAGR over the forecast period. Patient engagement software and hardware form the core offering of the solution.
The services segment is one of the crucial parts of the effective operation of patient engagement solutions. It helps in leveraging and optimizing patient engagement solutions as per the customer needs and to maximize patient health outcomes.
By Functionality Analysis
The communication segment accounted for the largest revenue share of over 35.0% in 2021 as it forms the core offering of any patient engagement solution. This large share is attributed to a surge in demand and adoption of telehealth, mhealth, and other virtual communication solutions via audio, video, and text.
The health tracking and insights segment is projected to grow at the fastest rate of 18.8% over the forecast period. This is owing to the increasing integration of data analytics, AI, and machine learning to present actionable insights to patients and their care providers.
By Therapeutic Area Analysis
Chronic disease management dominated the market in 2021 with a revenue share of over 40.0%. The rising geriatric population in key markets, the prevalence of chronic diseases, and the adoption of digital technologies catalyzed by the COVID-19 pandemic have contributed to the large share of the segment.
The health and wellness segment is anticipated to expand at the fastest rate of 17.7% over the forecast period. This is owing to the initiatives by key companies, the expansion of product offerings to cover mental health, weight management, and pregnancy, and increasing research activities.
By Application Analysis
The outpatient health management segment dominated the market and held a revenue share of over 35.0% in 2021. The others application segment, which includes R&D and preventive care, is anticipated to expand at the fastest rate of 17.7% over the forecast period.
Patient engagement solutions also help the patients to connect with their healthcare providers from remote locations, thereby enabling the streamlined flow of information, patient feedback, and other health-related data.
By End-user Analysis
Providers held the largest revenue share of over 45.0% in 2021. Providers serve the largest volume of patients and are also the primary line of treatment for consultation from general to specialist health concerns. These end users are thus the largest adopters of patient engagement solutions.
The payers end-user segment is estimated to expand at the fastest rate of 17.6% over the forecast period. The growth of the payers segment can be attributed to the increasing adoption of patient and customer engagement solutions that promote widespread coverage and enable value-based care delivery.
By Regional Analysis
North America held the largest revenue share of over 35.0% in 2021 due to the presence of key players, increasing adoption of mhealth and EHR, and growing investment in patient engagement software by the major companies.
The Asia Pacific market is expected to register a lucrative growth rate of 18.8% during the estimated period. The growing penetration of the internet and smartphone users, a large patient population, improving healthcare infrastructure and care quality, and the presence of local players are some of the key factors that are anticipated to offer lucrative growth opportunities to the market over the forecast period.
Global Patient engagement solutions market report provides key statistics on the state of the trade and could be a valuable supply of steerage and direction for corporations and people curious about the market. The Patient engagement solutions trade trends and promoting channels analysed. Patient engagement solutions Market discovers numerous topics like regional market scope, product market numerous applications, market size consistent with specific product, sales and revenue by region, producing analysis, Industrial Chain, Market result Factors Analysis, market size forecast, and more. Finally, the practicableness of latest investment comes is evaluated and overall analysis conclusions offered.
Key Players
Market Segmentation
Global Patient engagement solutions Market: Drivers and Restrains
The analysis report has incorporated the analysis of various factors that augment the market’s growth. It constitutes trends, restraints, and drivers that remodel the market in either a positive or negative manner. This section additionally provides the scope of various segments and applications that may probably influence the market within the future. The elaborated info is predicated on current trends and historic milestones. This section additionally provides an analysis of the amount of production regarding the world market and regarding every kind from 2021-2030.
COVID-19 impact on the Patient engagement solutions market
COVID-19 is associate communicable disease caused by the novel coronavirus. for the most part unknown before this happening across the world, COVID-19 has captive from a regional crisis to a worldwide pandemic in precisely a matter of a number of weeks. the world Health Organization (WHO) declared COVID-19 as an epidemic on March 11, 2021.
COVID-19 has compact most the industries across the world by disrupting provide chains and impeding numerous industrial operations. COVID-19-responsive measures undertaken by governments, like lockdown and social distancing, led to the closure of producing plants in the initial stage of the pandemic. With only a few industrial operations allowed, the demand for numerous input product within the industrial sector has declined considerably.
Key Highlights Involved in the Market Research Report: –
Patient engagement solutions Market Study Coverage: It includes key market segments, key makers covered, the scope of product offered within the years thought of, world Patient engagement solutions Market and study objectives. in addition, it touches the segmentation study provided within the report on the idea of the sort of product and applications.
Patient engagement solutions Market executive Summary: This section emphasizes the key studies, market rate, competitive landscape, market drivers, trends, and problems additionally to the gross indicators.
Patient engagement solutions Market Production by Region: The report delivers knowledge associated with import and export, revenue, production, and key players of all regional markets studied area unit coated during this section.
Patient engagement solutions Market Profile of Manufacturers: Analysis of every market player profiled is elaborated during this section. This section conjointly provides SWOT analysis, products, production, value, capacity, and different very important factors of the individual player.
The report delivers a comprehensive study of all the segments and shares info concerning the leading regions within the market. This report additionally states import/export consumption, offer and demand Figures, cost, business share, policy, price, revenue, and gross margins.
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Patient Engagement Solutions Market, By Delivery Type
7.1. Patient Engagement Solutions Market, by Delivery Type, 2021-2030
7.1.1. Web & Cloud-based
7.1.1.1. Market Revenue and Forecast (2019-2030)
7.1.2. On-premise
7.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 8. Global Patient Engagement Solutions Market, By Application
8.1. Patient Engagement Solutions Market, by Application, 2021-2030
8.1.1. Software & Hardware
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Services
8.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Patient Engagement Solutions Market, By Functionality
9.1. Patient Engagement Solutions Market, by Functionality, 2021-2030
9.1.1. Communication
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Health Tracking & Insights
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Billing & Payments
9.1.3.1. Market Revenue and Forecast (2019-2030)
9.1.4. Administrative
9.1.4.1. Market Revenue and Forecast (2019-2030)
9.1.5. Patient Education
9.1.5.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Patient Engagement Solutions Market, By Therapeutic Area
10.1. Patient Engagement Solutions Market, by Therapeutic Area, 2021-2030
10.1.1. Health & Wellness
10.1.1.1. Market Revenue and Forecast (2019-2030)
10.1.2. Chronic Disease Management
10.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 11. Global Patient Engagement Solutions Market, By Application
11.1. Patient Engagement Solutions Market, by Application, 2021-2030
11.1.1. Population Health Management
11.1.1.1. Market Revenue and Forecast (2019-2030)
11.1.2. Outpatient Health Management
11.1.2.1. Market Revenue and Forecast (2019-2030)
11.1.3. In-patient Health Management
11.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 12. Global Patient Engagement Solutions Market, By End-user
12.1. Patient Engagement Solutions Market, by End-user, 2021-2030
12.1.1. Payers
12.1.1.1. Market Revenue and Forecast (2019-2030)
12.1.2. Providers
12.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 13. Global Patient Engagement Solutions Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.1.2. Market Revenue and Forecast, by Application (2019-2030)
13.1.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.1.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.1.5. Market Revenue and Forecast, by Application (2019-2030)
13.1.6. Market Revenue and Forecast, by End-user (2019-2030)
13.1.7. U.S.
13.1.7.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.1.7.2. Market Revenue and Forecast, by Application (2019-2030)
13.1.7.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.1.7.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.1.7.5. Market Revenue and Forecast, by Application (2019-2030)
13.1.7.6. Market Revenue and Forecast, by End-user (2019-2030)
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.1.8.2. Market Revenue and Forecast, by Application (2019-2030)
13.1.8.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.1.8.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.1.8.5. Market Revenue and Forecast, by Application (2019-2030)
13.1.8.6. Market Revenue and Forecast, by End-user (2019-2030)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.2.2. Market Revenue and Forecast, by Application (2019-2030)
13.2.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.2.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.2.5. Market Revenue and Forecast, by Application (2019-2030)
13.2.6. Market Revenue and Forecast, by End-user (2019-2030)
13.2.7. UK
13.2.7.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.2.7.2. Market Revenue and Forecast, by Application (2019-2030)
13.2.7.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.2.7.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.2.7.5. Market Revenue and Forecast, by Application (2019-2030)
13.2.7.6. Market Revenue and Forecast, by End-user (2019-2030)
13.2.8. Germany
13.2.8.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.2.8.2. Market Revenue and Forecast, by Application (2019-2030)
13.2.8.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.2.8.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.2.8.5. Market Revenue and Forecast, by Application (2019-2030)
13.2.8.6. Market Revenue and Forecast, by End-user (2019-2030)
13.2.9. France
13.2.9.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.2.9.2. Market Revenue and Forecast, by Application (2019-2030)
13.2.9.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.2.9.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.2.9.5. Market Revenue and Forecast, by Application (2019-2030)
13.2.9.6. Market Revenue and Forecast, by End-user (2019-2030)
13.2.10. Rest of Europe
13.2.10.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.2.10.2. Market Revenue and Forecast, by Application (2019-2030)
13.2.10.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.2.10.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.2.10.5. Market Revenue and Forecast, by Application (2019-2030)
13.2.10.6. Market Revenue and Forecast, by End-user (2019-2030)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.3.2. Market Revenue and Forecast, by Application (2019-2030)
13.3.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.3.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.3.5. Market Revenue and Forecast, by Application (2019-2030)
13.3.6. Market Revenue and Forecast, by End-user (2019-2030)
13.3.7. India
13.3.7.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.3.7.2. Market Revenue and Forecast, by Application (2019-2030)
13.3.7.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.3.7.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.3.7.5. Market Revenue and Forecast, by Application (2019-2030)
13.3.7.6. Market Revenue and Forecast, by End-user (2019-2030)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.3.8.2. Market Revenue and Forecast, by Application (2019-2030)
13.3.8.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.3.8.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.3.8.5. Market Revenue and Forecast, by Application (2019-2030)
13.3.8.6. Market Revenue and Forecast, by End-user (2019-2030)
13.3.9. Japan
13.3.9.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.3.9.2. Market Revenue and Forecast, by Application (2019-2030)
13.3.9.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.3.9.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.3.9.5. Market Revenue and Forecast, by Application (2019-2030)
13.3.9.6. Market Revenue and Forecast, by End-user (2019-2030)
13.3.10. Rest of APAC
13.3.10.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.3.10.2. Market Revenue and Forecast, by Application (2019-2030)
13.3.10.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.3.10.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.3.10.5. Market Revenue and Forecast, by Application (2019-2030)
13.3.10.6. Market Revenue and Forecast, by End-user (2019-2030)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.4.2. Market Revenue and Forecast, by Application (2019-2030)
13.4.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.4.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.4.5. Market Revenue and Forecast, by Application (2019-2030)
13.4.6. Market Revenue and Forecast, by End-user (2019-2030)
13.4.7. GCC
13.4.7.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.4.7.2. Market Revenue and Forecast, by Application (2019-2030)
13.4.7.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.4.7.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.4.7.5. Market Revenue and Forecast, by Application (2019-2030)
13.4.7.6. Market Revenue and Forecast, by End-user (2019-2030)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.4.8.2. Market Revenue and Forecast, by Application (2019-2030)
13.4.8.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.4.8.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.4.8.5. Market Revenue and Forecast, by Application (2019-2030)
13.4.8.6. Market Revenue and Forecast, by End-user (2019-2030)
13.4.9. South Africa
13.4.9.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.4.9.2. Market Revenue and Forecast, by Application (2019-2030)
13.4.9.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.4.9.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.4.9.5. Market Revenue and Forecast, by Application (2019-2030)
13.4.9.6. Market Revenue and Forecast, by End-user (2019-2030)
13.4.10. Rest of MEA
13.4.10.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.4.10.2. Market Revenue and Forecast, by Application (2019-2030)
13.4.10.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.4.10.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.4.10.5. Market Revenue and Forecast, by Application (2019-2030)
13.4.10.6. Market Revenue and Forecast, by End-user (2019-2030)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.5.2. Market Revenue and Forecast, by Application (2019-2030)
13.5.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.5.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.5.5. Market Revenue and Forecast, by Application (2019-2030)
13.5.6. Market Revenue and Forecast, by End-user (2019-2030)
13.5.7. Brazil
13.5.7.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.5.7.2. Market Revenue and Forecast, by Application (2019-2030)
13.5.7.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.5.7.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.5.7.5. Market Revenue and Forecast, by Application (2019-2030)
13.5.7.6. Market Revenue and Forecast, by End-user (2019-2030)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.5.8.2. Market Revenue and Forecast, by Application (2019-2030)
13.5.8.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.5.8.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.5.8.5. Market Revenue and Forecast, by Application (2019-2030)
13.5.8.6. Market Revenue and Forecast, by End-user (2019-2030)
Chapter 14. Company Profiles
14.1. Cerner Corporation (Oracle)
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. NextGen Healthcare, Inc.
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Epic Systems Corporation
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Allscripts Healthcare, LLC
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. McKesson Corporation
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. ResMed
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Koninklijke Philips N.V.
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Klara Technologies, Inc.
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. CPSI
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Experian Information Solutions, Inc.
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/39139
About Us: Vision Research Reports is unquestionably an expert in providing research reports on a diverse number of subjects including Alternative and Green Energy, Chemical, Energy, Glass, Machinery, Manufacturing, and Pharmaceuticals and Materials. We cater to distinguished MNCs, private equity firms, SMEs and Chinese companies pertaining to their market research data requirements.
We offer generic and amalgamated studies as well as customized studies to our clients based on their specific requirements. Our modus operandi constitutes of detailed and meticulous market surveys, company profiling, competitive landscaping and primary interviews. Our prudent insights have been vital in the inception of many investment programs, new project development programs, startups and technology breakthroughs.
Contact Us:
Call: +1 9197 992 333
Vision Research Reports
Any Assistance, Email – sales@visionresearchreports.com
Vision Research Report, Recently Announced New Report on "Smart Lock market - Global Industry Analysis,…
Vision Research Report, Recently Announced New Report on "2D barcode reader market - Global Industry…
Vision Research Report, Recently Announced New Report on "commercial refrigeration equipment market - Global Industry…
Vision Research Report, Recently Announced New Report on "Restaurant Point-of-Sale Terminal market - Global Industry…
Vision Research Report, Recently Announced New Report on "vacuum cleaner market- Global Industry Analysis, Market…
Vision Research Report, Recently Announced New Report on "household refrigerators and freezers market - Global…